Distribution and drug resistance of Acinetobacter in 2005 to 2007.
Yan Zeng
Abstract
Yan Zeng
Abstract
Objective.To investigate the distribution and drug resistance of Acinetobacter spp.in our hospital. Methods The drug resistacne of of Acinetobacter spp.isolated from 1 st January 2005 to31st December 2007 in our hospital was monitored. Results There 446 strains of Acinetobacter spp.were isolated including 395 strains of Acinetobacter baumannii(88.6%),29 strains of Acinetobacter lwoffii(6.5%).There 75.8% Acinetobacter spp were isolated from respiratory samples,4.3% from blood samples.The resistance rates of Acinetobacter spp to cefoperazone/sulbactam,imipenem,meropenem were all less than 20%. Conclusion Acinetobacter spp show low resistance to cefoperazone/sulbactam,imipenem,meropenem.But rational use of antibiotics is necessary for delay the development of drug reissitance.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective.To investigate the distribution and drug resistance of Acinetobacter spp.in our hospital. Methods The drug resistacne of of Acinetobacter spp.isolated from 1 st January 2005 to31st December 2007 in our hospital was monitored. Results There 446 strains of Acinetobacter spp.were isolated including 395 strains of Acinetobacter baumannii(88.6%),29 strains of Acinetobacter lwoffii(6.5%).There 75.8% Acinetobacter spp were isolated from respiratory samples,4.3% from blood samples.The resistance rates of Acinetobacter spp to cefoperazone/sulbactam,imipenem,meropenem were all less than 20%. Conclusion Acinetobacter spp show low resistance to cefoperazone/sulbactam,imipenem,meropenem.But rational use of antibiotics is necessary for delay the development of drug reissitance.
Key concepts: Meropenem, Acinetobacter, Cefoperazone, Sulbactam, Acinetobacter baumannii, Imipenem, Microbiology, Drug resistance